German Pharmaceuticals & Biotech Potentially Undervalued Companies

Shanghai Junshi Biosciences

Market Cap: €46.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China.

Chugai Pharmaceutical

Market Cap: €11.1t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Tilray Brands

Market Cap: €1.4b

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Mesoblast

Market Cap: €2.9b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Organogenesis Holdings

Market Cap: €616.5m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Vertex Pharmaceuticals

Market Cap: €100.3b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Astellas Pharma

Market Cap: €3.0t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Krka d. d

Market Cap: €6.7b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

Telix Pharmaceuticals

Market Cap: €4.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Vertex Pharmaceuticals

Market Cap: €100.3b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Livzon Pharmaceutical Group

Market Cap: €33.4b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China.

Inovio Pharmaceuticals

Market Cap: €121.2m

A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

Telescope Innovations

Market Cap: €23.5m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

Enzon Pharmaceuticals

Market Cap: €6.7m

Does not have significant operations.

AVEO Pharmaceuticals

Market Cap: €521.4m

AVEO Pharmaceuticals, Inc., an oncology-focused biopharmaceutical company, focuses on developing and commercializing medicines for patients with cancer.

X4 Pharmaceuticals

Market Cap: €8.7m

A biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.

Evoke Pharma

Market Cap: €5.8m

Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

Assembly Biosciences

Market Cap: €319.8m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

TherapeuticsMD

Market Cap: €12.5m

Operates as a pharmaceutical royalty company in the United States.

Coherus Oncology

Market Cap: €158.1m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

Roche Holding

Market Cap: €223.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Geron

Market Cap: €797.5m

A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

Ascendis Pharma

Market Cap: €11.9b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Johnson & Johnson

Market Cap: €425.0b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

PDS Biotechnology

Market Cap: €56.4m

A clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies.

ArcticZymes Technologies

Market Cap: €1.3b

A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.

Apellis Pharmaceuticals

Market Cap: €3.0b

A commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs.

Chugai Pharmaceutical

Market Cap: €11.1t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

CRISPR Therapeutics

Market Cap: €5.6b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

BioNTech

Market Cap: €23.9b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Vericel

Market Cap: €1.7b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Alterity Therapeutics

Market Cap: €119.6m

Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.

Kyowa Kirin

Market Cap: €1.2t

Engages in the research, development, manufacturing, sells, and import/export of pharmaceuticals products worldwide.

Gilead Sciences

Market Cap: €137.6b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Sartorius Stedim Biotech

Market Cap: €17.3b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

CSL

Market Cap: €97.4b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.